Stan Gee Louie Promoted to Professor, Titus Family Department of Clinical Pharmacy

Stan Gee Louie was promoted to Professor in the Titus Family Department of Clinical Pharmacy, effective March 8.

Louie, a clinical and translational pharmacologist with over three decades of clinical and drug development experience, is nationally recognized for his translational research spanning HIV, cancer and neurodegenerative disorders. His laboratory focuses on drug development for the treatment of infections, malignancies (e.g. HTLV-linked leukemia, Kaposi’s sarcoma) and neurodegenerative diseases as well as traumatic brain injury and ophthalmologic injury.

A USC faculty member since 1989, he is highly regarded by students as an effective and dedicated teacher and as a mentor to graduate students. Under his leadership as Director of the Clinical and Experimental Therapeutics (CXPT) graduate program, the School recently developed a new Master of Science degree program, which emphasizes research in translating basic science discovery in chemistry, pharmacogenomics, molecular pharmacology, inflammatory diseases, infectious disease and oncology into therapeutic modalities.

A 1987 graduate of UC San Francisco, Louie continued his clinical training at California Pacific Medical Center (CPMC), then accepted a position at USC, where he began his academic career investigating cancer therapy and bone marrow transplantation.

“We are very fortunate to have him as a member of the faculty,” said Paul Beringer, Associate Professor and Chair of Titus Family Department of Clinical Pharmacy, as he announced Louie’s promotion.